Canaccord analyst Kyle Rose raised the firm’s price target on Stryker to $250 from $220 and keeps a Hold rating on the shares. The analyst said they delivered a strong Q4 despite continued supply chain, inflationary, and FX headwinds, beating on the top and bottom lines.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SYK: